Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia

Relapsed and refractory acute myeloid leukemia (AML) carries a dismal prognosis. CAR T cells have shown limited efficacy in AML, partially due to dysfunctional autologous T cells and the extended time for generation of patient specific CAR T cells. Allogeneic NK cell therapy is a promising alternati...

Full description

Saved in:
Bibliographic Details
Main Authors: Sedloev, David (Author) , Chen, Qian (Author) , Unglaub, Julia Marie (Author) , Schanda, Nicola (Author) , Yao, Hao (Author) , Besiridou, Eleni (Author) , Neuber, Brigitte (Author) , Schmitt, Anita (Author) , Raffel, Simon (Author) , Liu, Yi (Author) , Janssen, Maike (Author) , Müller-Tidow, Carsten (Author) , Schmitt, Michael (Author) , Sauer, Tim (Author)
Format: Article (Journal)
Language:English
Published: 16 September 2024
In: Journal of hematology & oncology
Year: 2024, Volume: 17, Pages: 1-22
ISSN:1756-8722
DOI:10.1186/s13045-024-01604-y
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13045-024-01604-y
Verlag, kostenfrei, Volltext: https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01604-y
Get full text
Author Notes:David Sedloev, Qian Chen, Julia M. Unglaub, Nicola Schanda, Yao Hao, Eleni Besiridou, Brigitte Neuber, Anita Schmitt, Simon Raffel, Yi Liu, Maike Janssen, Carsten Müller-Tidow, Michael Schmitt and Tim Sauer

MARC

LEADER 00000caa a2200000 c 4500
001 1916799620
003 DE-627
005 20250716231158.0
007 cr uuu---uuuuu
008 250210s2024 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13045-024-01604-y  |2 doi 
035 |a (DE-627)1916799620 
035 |a (DE-599)KXP1916799620 
035 |a (OCoLC)1528019008 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sedloev, David  |e VerfasserIn  |0 (DE-588)1252255403  |0 (DE-627)1793382204  |4 aut 
245 1 0 |a Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia  |c David Sedloev, Qian Chen, Julia M. Unglaub, Nicola Schanda, Yao Hao, Eleni Besiridou, Brigitte Neuber, Anita Schmitt, Simon Raffel, Yi Liu, Maike Janssen, Carsten Müller-Tidow, Michael Schmitt and Tim Sauer 
264 1 |c 16 September 2024 
300 |b Illustrationen 
300 |a 22 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.02.2025 
520 |a Relapsed and refractory acute myeloid leukemia (AML) carries a dismal prognosis. CAR T cells have shown limited efficacy in AML, partially due to dysfunctional autologous T cells and the extended time for generation of patient specific CAR T cells. Allogeneic NK cell therapy is a promising alternative, but strategies to enhance efficacy and persistence may be necessary. Proteasome inhibitors (PI) induce changes in the surface proteome which may render malignant cells more vulnerable to NK mediated cytotoxicity. Here, we investigated the potential benefit of combining PIs with CAR-expressing allogeneic NK cells against AML. 
700 1 |a Chen, Qian  |d 1992-  |e VerfasserIn  |0 (DE-588)1340528126  |0 (DE-627)1900545535  |4 aut 
700 1 |a Unglaub, Julia Marie  |e VerfasserIn  |0 (DE-588)1247235157  |0 (DE-627)1780861508  |4 aut 
700 1 |a Schanda, Nicola  |e VerfasserIn  |0 (DE-588)1254637869  |0 (DE-627)1797304127  |4 aut 
700 1 |a Yao, Hao  |d 1992-  |e VerfasserIn  |0 (DE-588)1286858801  |0 (DE-627)1843456370  |4 aut 
700 1 |a Besiridou, Eleni  |e VerfasserIn  |0 (DE-588)1355860350  |0 (DE-627)1916802850  |4 aut 
700 1 |a Neuber, Brigitte  |d 1974-  |e VerfasserIn  |0 (DE-588)1052913563  |0 (DE-627)789293188  |0 (DE-576)408653884  |4 aut 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Raffel, Simon  |d 1978-  |e VerfasserIn  |0 (DE-588)144030918  |0 (DE-627)65682039X  |0 (DE-576)339840404  |4 aut 
700 1 |a Liu, Yi  |e VerfasserIn  |0 (DE-588)1164192132  |0 (DE-627)1028654979  |0 (DE-576)508429986  |4 aut 
700 1 |a Janssen, Maike  |e VerfasserIn  |0 (DE-588)1190667665  |0 (DE-627)166922645X  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
700 1 |a Sauer, Tim  |d 1981-  |e VerfasserIn  |0 (DE-588)138282013  |0 (DE-627)601099516  |0 (DE-576)307058166  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hematology & oncology  |d London : Biomed Central, 2008  |g 17(2024), Artikel-ID 85, Seite 1-22  |h Online-Ressource  |w (DE-627)568914813  |w (DE-600)2429631-4  |w (DE-576)281703132  |x 1756-8722  |7 nnas  |a Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia 
773 1 8 |g volume:17  |g year:2024  |g elocationid:85  |g pages:1-22  |g extent:22  |a Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia 
856 4 0 |u https://doi.org/10.1186/s13045-024-01604-y  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01604-y  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250210 
993 |a Article 
994 |a 2024 
998 |g 138282013  |a Sauer, Tim  |m 138282013:Sauer, Tim  |d 910000  |d 910100  |e 910000PS138282013  |e 910100PS138282013  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 13 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1190667665  |a Janssen, Maike  |m 1190667665:Janssen, Maike  |d 910000  |d 910100  |e 910000PJ1190667665  |e 910100PJ1190667665  |k 0/910000/  |k 1/910000/910100/  |p 11 
998 |g 1164192132  |a Liu, Yi  |m 1164192132:Liu, Yi  |d 910000  |d 910100  |e 910000PL1164192132  |e 910100PL1164192132  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 144030918  |a Raffel, Simon  |m 144030918:Raffel, Simon  |d 910000  |d 910100  |e 910000PR144030918  |e 910100PR144030918  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |d 50000  |e 910000PS141722495  |e 910100PS141722495  |e 50000PS141722495  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 8 
998 |g 1052913563  |a Neuber, Brigitte  |m 1052913563:Neuber, Brigitte  |d 910000  |d 910100  |e 910000PN1052913563  |e 910100PN1052913563  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1355860350  |a Besiridou, Eleni  |m 1355860350:Besiridou, Eleni  |d 910000  |d 910100  |d 140000  |e 910000PB1355860350  |e 910100PB1355860350  |e 140000PB1355860350  |k 0/910000/  |k 1/910000/910100/  |k 0/140000/  |p 6 
998 |g 1286858801  |a Yao, Hao  |m 1286858801:Yao, Hao  |d 50000  |e 50000PY1286858801  |k 0/50000/  |p 5 
998 |g 1247235157  |a Unglaub, Julia Marie  |m 1247235157:Unglaub, Julia Marie  |d 910000  |d 910100  |e 910000PU1247235157  |e 910100PU1247235157  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1340528126  |a Chen, Qian  |m 1340528126:Chen, Qian  |d 50000  |e 50000PC1340528126  |k 0/50000/  |p 2 
998 |g 1252255403  |a Sedloev, David  |m 1252255403:Sedloev, David  |d 910000  |d 910100  |e 910000PS1252255403  |e 910100PS1252255403  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1916799620  |e 4662722845 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia","title_sort":"Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia"}],"language":["eng"],"person":[{"family":"Sedloev","given":"David","display":"Sedloev, David","role":"aut"},{"family":"Chen","given":"Qian","display":"Chen, Qian","role":"aut"},{"role":"aut","family":"Unglaub","given":"Julia Marie","display":"Unglaub, Julia Marie"},{"role":"aut","display":"Schanda, Nicola","given":"Nicola","family":"Schanda"},{"role":"aut","display":"Yao, Hao","given":"Hao","family":"Yao"},{"role":"aut","given":"Eleni","display":"Besiridou, Eleni","family":"Besiridou"},{"family":"Neuber","given":"Brigitte","display":"Neuber, Brigitte","role":"aut"},{"family":"Schmitt","display":"Schmitt, Anita","given":"Anita","role":"aut"},{"family":"Raffel","display":"Raffel, Simon","given":"Simon","role":"aut"},{"role":"aut","family":"Liu","given":"Yi","display":"Liu, Yi"},{"given":"Maike","display":"Janssen, Maike","family":"Janssen","role":"aut"},{"given":"Carsten","display":"Müller-Tidow, Carsten","family":"Müller-Tidow","role":"aut"},{"role":"aut","family":"Schmitt","display":"Schmitt, Michael","given":"Michael"},{"given":"Tim","display":"Sauer, Tim","family":"Sauer","role":"aut"}],"name":{"displayForm":["David Sedloev, Qian Chen, Julia M. Unglaub, Nicola Schanda, Yao Hao, Eleni Besiridou, Brigitte Neuber, Anita Schmitt, Simon Raffel, Yi Liu, Maike Janssen, Carsten Müller-Tidow, Michael Schmitt and Tim Sauer"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"16 September 2024"}],"recId":"1916799620","note":["Gesehen am 10.02.2025"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2008 -"],"titleAlt":[{"title":"Journal of hematology and oncology"}],"language":["eng"],"recId":"568914813","disp":"Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemiaJournal of hematology & oncology","note":["Gesehen am 19.06.2020"],"part":{"text":"17(2024), Artikel-ID 85, Seite 1-22","volume":"17","extent":"22","year":"2024","pages":"1-22"},"id":{"eki":["568914813"],"issn":["1756-8722"],"zdb":["2429631-4"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of hematology & oncology","title_sort":"Journal of hematology & oncology"}],"origin":[{"publisher":"Biomed Central","dateIssuedDisp":"2008-","dateIssuedKey":"2008","publisherPlace":"London"}]}],"physDesc":[{"extent":"22 S.","noteIll":"Illustrationen"}],"id":{"eki":["1916799620"],"doi":["10.1186/s13045-024-01604-y"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a SEDLOEVDAVPROTEASOME1620